Highlights of ECTRIMS 2009

Düsseldorf, Germany
September 9 – 12, 2009

HIGHLIGHTS          DAILY COVERAGE

This issue of Neura Special Report features highlights from the 25th Congress of the European Committee For Treatment and Research in Multiple Sclerosis (ECTRIMS).


  Download the Full Coverage

• An overview of the latest research into the clinical significance of neutralizing antibodies.
• New research using quality of life quality of life measures helps to elucidate the effects of disease-modifying therapies (DMTs) and social support in MS patients.
• Experimental and clinical findings suggest potential neuroprotective effects of various DMTs.
• Cellular research sheds insight into the interaction between oral MS therapies and the body’s immune cells.
• Study results expand our knowledge of the role of B cells in MS.
• Updates on the long-term outcomes of progressive MS subtypes.
• Results from a study indicate that treatment with an endocannabinoid system modulator reduces spasticity in MS.
• Data on the return of disease activity after drug discontinuation and the detection of the JC virus.
• Statistics describing the prevalence of the use of complementary and alternative medicine in MS patients.
• Surprising findings reveal that dental care is often overlooked in MS care.

	Understanding Neutralizing Antibodies
	Measuring Quality of Life in MS Patients
	Data Suggest Neuroprotective Effects
	Immune Cell Effects of Oral Therapies
	B Cells: Disease and Treatment Effects
	Treatment Reduces MS Spasticity
	Long-Term Outcomes of Progressive MS Subtypes
	Posttreatment Activity and JC Virus
	Prevalence of CAM Use in the US
	Dental Care Overlooked in MS Patients

GUEST EDITORS:
Patricia K. Coyle, MD
Professor and Acting Chair of Neurology
Director, Stony Brook MS Comprehensive Care Center
Department of Neurology
Stony Brook University Medical Center
Stony Brook, New York

Stephen S. Kirzinger, MD
Medical Director, MS Care Center Program
Associate Professor
Department of Neurology
University of Louisville Medical School
Louisville, Kentucky

Neura On-Site coverage of the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis held in Düsseldorf, Germany, includes select presentations presented on Wednesday, September 9–Saturday, September 12, 2009.